MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Amyotrophic lateral sclerosis"

  • 2023 International Congress

    Predicting ALS progression using remote sensor-based assessments

    D. Anderson, A. Keil, D. Amato, M. Merickel, M. Kantartjis, S. Jezewski, S. Johnson, S. Polyak, B. Severson, J. Severson (Horsham, USA)

    Objective: To develop a predictive model of amyotrophic lateral sclerosis (ALS) progression using self-administered digital assessments. Background: Remote fit-for-purpose sensor-based assessments stand to enhance the…
  • 2022 International Congress

    What if it is not a Functional Movement Disorder?

    A. López-Jiménez, M. Kurtis, I. Pareés (Madrid, Spain)

    Objective: To describe a consecutive cohort of patients with non-functional neurological diseases that were initially diagnosed as Functional Movement Disorders (FMD). Background: Functional and non-Functional…
  • MDS Virtual Congress 2021

    Amyotrophic Lateral Sclerosis with SOD1 mutation presenting with progressive cerebellar ataxia

    M. Sequeira, P. Faustino, J. Lourenço (Lisboa, Portugal)

    Objective: To present a rare case of Amyotrophic Lateral Sclerosis (ALS) with cerebellar ataxia onset. Background: ALS is a fatal neurodegenerative disorder known to affect…
  • MDS Virtual Congress 2021

    Rare Neurodegenerative Phenotypes in Patients Carrying Homozygous GBA1 Mutations

    G. Lopez, N. Tayebi, M. Hallett, A. Zimran, P. Kishnani, E. Sidransky (Bethesda, USA)

    Objective: To describe patients with Type 1 Gaucher disease who developed a rare neurodegenerative disease other than synucleinopathies. Background: Lysosomal dysfunction as a contributor to…
  • MDS Virtual Congress 2020

    Oral treatment of the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis (ALS) with the neuro-inflammation inhibiting compound PRI-003

    J. Post-Schulz, A. Schaffrath, A. Willuweit, D. Willbold, J. Kutzsche (Jülich, Germany)

    Objective: Demonstration of beneficial effects of neuro-inflammation inhibition for the treatment of amyotrophic lateral sclerosis (ALS). Background: Neuro-inflammation and immune-inflammatory processes are characteristics of the…
  • MDS Virtual Congress 2020

    Kinematic assessment of bradykinesia in patients with amyotrophic lateral sclerosis

    G. Paparella, M. Bologna, D. Colella, A. Cannavacciuolo, M. Ceccanti, A. Guerra, M. Inghilleri, A. Berardelli (Pozzilli, Italy)

    Objective: To kinematically assess abnormalities of voluntary upper limbs movements in patients with amyotrophic lateral sclerosis compared to healthy subjects. To investigate possible relationships between…
  • 2019 International Congress

    Ataxin-2 gene in the Cuban population: Mutagenesis and epigenetic DNA methylation disease influencing phenotype

    J. Laffita-Mesa, L. Velazquez Perez (Stockholm, Sweden)

    Objective: To characterize genetics and epigenetics factors contributing to the origin and accounting to the Cuban SCA2 phenotype variability. Background: CAG repeat expansions in ATXN2…
  • 2019 International Congress

    The potential modifier effect of C9orf72 DNA methylation in C9ORF72 carriers

    JM. Laffita-Mesa, CH. Kreidy, M. Paucar, P. Svenningsson (Stockholm, Sweden)

    Objective: To develop molecular assays for determining the influence of hypermethylation on age of onset for C9ORF72 carriers. Background: Hexanucleotide repeats of GGGGCC in C9ORF72 is…
  • 2018 International Congress

    “Wine glass” appearance in a primary lateral sclerosis and frontotemporal dementia case

    M. Velez, L. Torres (Lima, Peru)

    Objective: Primary lateral sclerosis is a very uncommon progressive disease and represents 2-4% of motor neuron diseases group. It is characterized by spasticity because corticospinal…
  • 2018 International Congress

    On the hunt for a link between genetically confirmed Huntington’s disease and Amyotrophic Lateral Sclerosis

    L. Williams, K. O'Connell, D. Burke, J. Cryan, D. McCabe (Dublin, Ireland)

    Objective: To characterise the clinical and pathologic findings of Huntington’s disease (HD) and coincident amyotrophic lateral sclerosis (ALS). Background: A 66 year old man presented…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley